États-Unis · Plateformes & données · TipRanks

Neurosterix Closes $105 Million Series B Financing

Publié par TipRanks · États-Unis il y a 10 h

Résumé détaillé

Addex Therapeutics ( ($CH:ADXN) ) has issued an announcement. Addex Therapeutics, a clinical-stage biopharmaceutical company developing small-molecule allosteric ...

Lire l'article complet sur TipRanks Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.tipranks.com)

Neurosterix Closes $105 Million Series B Financing

Résumé détaillé

À lire aussi

Automatic Data Processing, Inc. (NASDAQ:ADP) Plans Quarterly Dividend of $1.90

Dell Technologies vs. Taiwan Semiconductor: Which Technology Stock Is a Better Buy for 2027?

Your holiday credit-card bills are going up. What you can do to ease the pain.

Here are the major earnings before the open Thursday

AEVEX Q3 2026 slides: core business surges as Ukraine revenue fades

Prediction markets tied to clinical trials and drug approvals draw lawmakers' ire

Neurosterix Closes $105 Million Series B Financing

Résumé détaillé

Partager

À lire aussi

Automatic Data Processing, Inc. (NASDAQ:ADP) Plans Quarterly Dividend of $1.90

Dell Technologies vs. Taiwan Semiconductor: Which Technology Stock Is a Better Buy for 2027?

Your holiday credit-card bills are going up. What you can do to ease the pain.

Here are the major earnings before the open Thursday

AEVEX Q3 2026 slides: core business surges as Ukraine revenue fades

Prediction markets tied to clinical trials and drug approvals draw lawmakers' ire